Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
Date
2020Journal
Frontiers in NeurologyPublisher
Frontiers Media S.A.Type
Article
Metadata
Show full item recordKeyword
brainclinical trials
ischemia
mesenchymal stem cells (MSC)
stem cells
stroke
translational medicine
treatment
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083499635&doi=10.3389%2ffneur.2020.00171&partnerID=40&md5=91ef443aacdddcd768f5ba0521084220; http://hdl.handle.net/10713/12671ae974a485f413a2113503eed53cd6c53
10.3389/fneur.2020.00171